Regulation of p21(WAF1) expression during normal myeloid differentiation

Blood

Volumn 91, Issue 12, 1998, Pages 4531-4542

  Steinman, Richard A ^a,b   Huang, Jianping ^a   Yaroslavskiy, Beatrice ^a   Goff, Julie P ^a   Ball, Edward D ^a   Nguyen, Aline ^a  

^a UNIVERSITY OF PITTSBURGH CANCER INSTITUTE   (United States)

^b UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; DNA; GRANULOCYTE COLONY STIMULATING FACTOR; PROTEIN P21; PROTEIN P53; RNA;

ARTICLE; BONE MARROW CELL; CELL DIFFERENTIATION; CONTROLLED STUDY; DNA SEQUENCE; GENE EXPRESSION REGULATION; HEMATOPOIETIC STEM CELL; HUMAN; HUMAN CELL; IN SITU HYBRIDIZATION; LEUKEMIA CELL; NEUTROPHIL; NORTHERN BLOTTING; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN BINDING; REGULATOR GENE; UMBILICAL CORD;

EID: 0031810568     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v91.12.4531.412k10_4531_4542     Document Type: Article

References (68)

1. Sachs L: Constitutive uncoupling of pathways of gene expression that control growth and differentiation in myeloid leukemia: A model for the origin and progression of malignancy. Proc Natl Acad Sci USA 77:6152, 1980
2. Pardee AB: G1 events and regulation of cell proliferation. Science 246:603, 1989
3. Furukawa Y, Uenoyama S, Ohta M, Tsunoda A, Griffin JD, Saito M: Transforming growth factor-beta inhibits phosphorylation of the retinoblastoma susceptibility gene product in human monocytic leukemia cell line JOSK-I. J Biol Chem 267:17121, 1992
4. Oberg, Botling, Nilsson: Functional antagonism between vitamin D3 and retinoic acid in the regulation of CD14 and CD23 expression during monocytic differentiation of U-937 cells. J Immunol 150:3487, 1993
5. Harper JW, Adami GR, Wei N, Keyomarsi K, Elledge SJ: The p21Cdk-interacting protein Cip1 is a potent inhibitor of G1-cyclin-dependent kinases. Cell 75:805, 1993
6. Dulic V, Kaufmann WK, Wilson SJ, Tisty TD, Lees E, Harper JW, Elledge SJ, Reed SI: p53-dependent inhibition of cyclin-dependent kinase activities in human fibroblasts during radiation-induced G1 arrest. Cell 76:1013, 1994
7. Xiong Y, Hannon GJ, Zhang H, Casso D, Kobayashi R, Beach D: p21 is a universal inhibitor of cyclin kinases. Nature 366:701, 1993
8. Gu Y, Turck CW, Morgan DO: Inhibition of Cdk2 activity in vivo by an associated 20K regulatory subunit. Nature 366:707, 1993
9. Luo Y, Hurwitz J, Massague J: Cell-cycle inhibition by independent CDK and PCNA binding domains in p21Cip1. Nature 375:159, 1995
10. Shiyanov P, Bagchi S, Adami G, Kokontis J, Hay N, Arroyo M, Morozov A, Raychaudhuri P: p21 disrupts the interaction between cdk2 and the e2f-p130 complex. Mol Cell Biol 16:737, 1996
11. Zhu L, Harlow E, Dynlacht BD: p107 uses a p21CIP1-related domain to bind cyclin/cdk2 and regulate interactions with E2F. Genes Dev 9:1740, 1995
12. Munger K, Pietenpol JA, Pittelkow MR, Holt JT, Moses HL: Transforming growth factor beta 1 regulation of c-myc expression, pRB phosphorylation, and cell cycle progression in keratinocytes. Cell Growth Differ 3:291, 1992
13. Adunyah SE, Unlap TM, Franklin CC, Kraft AS: Induction of differentiation and c-jun expression in human leukemic cells by okadaic acid, an inhibitor of protein phosphatases. J Cell Physiol 151:415, 1992
14. Chen P-L, Scully P, Shew J-Y, Wang JYJ, Lee W-H: Phosphorylation of the retinoblastoma gene product is modulated during the cell cycle and cellular differentiation. Cell 58:1193, 1989
15. Furukawa Y, DeCaprio JA, Freedman AY, Kanukura MN, Ernst TJ, Livingston DM, Griffin JD: Expression and state of phosphorylation of the retinoblastoma susceptibility gene product in cycling and noncycling human hematopoietic cells. Proc Natl Acad Sci USA 87:2770, 1990
16. Steinman RA, Hoffman B, Iro A, Guillouf C, Liebermann DA, El-Houseini ME: Induction of p21(WAF1/CIP1) during differentiation. Oncogene 9:3389, 1994
17. Jiang H, Lin J, Su ZZ, Collart FR, Huberman E, Fisher PB: Induction of differentiation in human promyelocytic HL-60 leukemia cells activates p21 WAF1/CIP1 expression in the absence of p53. Oncogene 9:3397, 1994
18. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travali S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668, 1995
19. Schwaller J, Koeffler HP, Niklaus G, Loetscher P, Nagel S, Fey MF, Tobler A: Posttranscriptional stabilization underlies p53-independent induction of p21(WAF1/CIP1/SDI1) in differentiating human leukemic cells. J Clin Invest 95:973, 1995
20. Biggs JR, Kudlow JE, Kraft AS: The role of the transcription factor Sp1 in regulating the expression of the WAF1/CIP1 gene in U937 cells. J Biol Chem 271:901, 1996
21. Liu M, Lee MH, Cohen M, Bommakanti M, Freedman LP: Transcriptional activation of the cdk inhibitor p21 by vitamin d-3 leads to the induced differentiation of the myelomonocytic cell line u937. Genes Dev 10:142, 1996
22. Halevy O, Novitch BG, Spicer DB, Skapek SX, Rhee J, Hannon GJ, Beach D, Lassar AB: Correlation of terminal cell cycle arrest of skeletal muscle with induction of p21 by MyoD. Science 267:1018, 1995
23. El-Deiry W, Tokino T, Waldman T, Oliner JD, Velculescu VE, Burrell M, Hill DE, Healy E, Rees JL, Hamilton SR, Kinzler KW, Vogelstein B: Topological control of p21(WAF1/CIP1) expression in normal and neoplastic tissues. Cancer Res 55:2910, 1995
24. Parker SB, Eichele G, Zhang P, Rawls A, Sands AT, Bradley A, Olson EN, Harper JW, Elledge SJ: p53-independent expression of p21Cip1 in muscle and other terminally differentiating cells. Science 267:1024, 1995
25. Poluha W, Poluha DK, Chang B, Crosbie NE, Schonhoff CM, Kilpatrick DL, Ross AH: The cyclin-dependent kinase inhibitor p21 (WAF1) is required for survival of differentiating neuroblastoma cells. Mol Cell Biol 16:1335, 1996
26. Polyak K, Waldman T, He TC, Kinzler KW, Vogelstein B: Genetic determinants of p53-induced apoptosis and growth arrest. Genes Dev 10:1945, 1996
27. Wang J, Walsh K: Resistance to apoptosis conferred by Cdk inhibitors during myocyte differentiation. Science 273:359, 1996
28. Gorospe M, Holbrook NJ: Role of p21 in prostaglandin A2-mediated cellular arrest and death. Cancer Res 56:475, 1996
29. El-Deiry WS, Tokino T, Velculescu VE, Levy DB, Parsons R, Trent JM, Lin D, Mercer WE, Kinzler KW, Vogelstein B: WAF1, a potential mediator of p53 tumor suppression. Cell 75:817, 1993
30. Elbendary A, Berchuck A, Davis P, Havrilesky L, Bast R Jr, Iglehart JD, Marks JR: Transforming growth factor beta 1 can induce CIP1/WAF1 expression independent of the p53 pathway in ovarian cancer cells. Cell Growth Differ 5:1301, 1994
31. Missero C, Calautti E, Eckner R, Chin J, Tsai LH, Livingston DM, Dotto GP: Involvement of the cell-cycle inhibitor Cip1/WAF1 and the E1A-associated p300 protein in terminal differentiation. Proc Natl Acad Sci USA 92:5451, 1995
32. Zhang W, Grasso L, McClain CD, Gambel AM, Cha Y, Travail S, Deisseroth AB, Mercer WE: p53-independent induction of WAF1/CIP1 in human leukemia cells is correlated with growth arrest accompanying monocyte/macrophage differentiation. Cancer Res 55:668, 1995
33. Liu, Lee M-H, Cohen MM, Freedman LP: Transcriptional activation of the Cdk-inhibitor p21 by vitamin D leads to the induced differentiation of the myelomonocytic cell line U937. Genes Dev 10:142, 1996
34. Chin YE, Kitagawa M, Su W, You ZH, Iwamoto Y, Fu XY: Cell growth arrest and induction of cyclin-dependent kinase inhibitor p21(waf1/cip1) mediated by stall. Science 272:719, 1996
35. Matsumura I, Ishikawa J, Nakajima K, Oritani K, Tomiyama Y, Miyagawa JI, Kato T, Miyazaki H, Matsuzawa Y, Kanakura Y: Thrombopoietin-induced differentiation of a human megakaryoblastic leukemia cell line, CMK, involves transcriptional activation of p21(WAF1/CIP1) by Stat5. Mol Cell Biol 17:2933, 1997
36. Miltenyi S, Guth S, Radbruch A: Isolation of CD34+ hematopoietic progenitor cells by high-gradient magnetic sorting, in Wunder E (ed): Hematopoetic Stem Cells. Dayton, OH, Alpha Med, 1994, p 201
37. Berliner N, Hsing A, Graubert T, Sigurdsson F, Zain M, Bruno E, Hoffman R: Granulocyte colony-stimulating factor induction of normal human bone arrow progenitors results in neutrophil-specific gene expression. Blood 85:799, 1995
38. Steinman RA, Tweardy DJ: Granulocyte colony stimulating factor receptor mRNA upregulation is an immediate early marker of myeloid differentiation and exhibits dysfunctional regulation in leukemic cells. Blood 83:119, 1994
39. Macleod KF, Sherry N, Hannon G, Beach D, Tokino T, Kinzler K, Vogelstein B, Jacks T: p53-dependent and independent expression of p21 during cell growth, differentiation and DNA damage. Genes Dev 9:935, 1995
40. Schrader M, Danielsson C, Wiesenberg I, Carlberg C: Identification of natural monomeric response elements of the nuclear receptor rzr/ror - They also bind coup-tf homodimers. J Biol Chem 271:19732, 1996
41. Zauberman A, Barak Y, Ragimov N, Levy N, Oren M: Sequence-specific DNA binding by p53: Identification of target sites and lack of binding to p53-MDM2 complexes. EMBO J 12:2799, 1993
42. Koeffler HP, Miller C, Nicolson MA, Ranyard J, Bosselman RA: Increased expression of p53 protein in human leukemia cells. Proc Natl Acad Sci USA 83:4035, 1986
43. Tweardy DJ, Wright TM, Ziegler SF, Baumann H, Chakraborty A, White SM, Dyer KF, Rubin KA: Granulocyte colony-stimulating factor rapidly activates a distinct STAT-like protein in normal myeloid cells. Blood 86:4409, 1995
44. Zhang W, Kornblau SM, Kobayashi T, Gambel A, Claxton D, Deisseroth AB: High levels of constitutive WAF1/CIP1 protein are associated with chemoresistance in acute myelogenous leukemia. Clin Cancer Res 1:1051, 1995
45. Timchenko NA, Wilde M, Nakanishi M, Smith JR, Darlington GJ: Ccaat/enhancer-binding protein alpha c/ebp-alpha inhibits cell proliferation through the p21 (waf-1/cip-1/sdi-1) protein. Genes Dev 10:804, 1996
46. Collins T, Read MA, Neish AS, Whitley MZ, Thanos D, Maniatis T: Transcriptional regulation of endothelial cell adhesion molecules: NF-kappa B and cytokine-inducible enhancers [Review]. FASEB J 9:899, 1995
47. Du W, Maniatis T: The high mobility group protein HMG I(Y) can stimulate or inhibit DNA binding of distinct transcription factor ATF-2 isoforms. Proc Natl Acad Sci USA 91:11318, 1994
48. Lehming N, Thanos D, Brickman JM, Ma J, Maniatis T, Ptashne M: An HMG-like protein that can switch a transcriptional activator to a repressor. Nature 371:175, 1994
49. Tran P, Zhang XK, Salbert G, Hermann T, Lehmann JM, Pfahl M: COUP orphan receptors are negative regulators of retinoic acid response pathways. Mol Cell Biol 12:4666, 1992
50. Forman BM, Chen J, Blumberg B, Kliewer SA, Henshaw R, Ong ES, Evans RM: Cross-talk among ROR alpha 1 and the Rev-erb family of orphan nuclear receptors. Mol Endocrinol 8:1253, 1994
51. Funaoka K, Shindoh M, Yoshida K, Hanzawa M, Hida K, Nishikata S, Totsuka Y, Fujinaga K: Activation of the p21(WAF1/CIP1) promoter by the ets oncogene family transcription factor E1AF. Biochem Biophys Res Commun 236:79, 1997
52. Quandt K, Frech K, Karas H, Wingender E, Werner T: Matlnd and MatInspector-New fast and versatile tools for detection of consensus matches in nucleotide sequence data. Nucleic Acids Res 23:4878, 1995
53. Wingender E, Kel AE, Kel OV, Karas H, Heinemyer T, Dietze P, Knueppel R, Romaschenko AG, Kolchanov NA: TRANSFAC, TRRD and COMPEL: Towards a federated database system on transcriptional regulation. Nucleic Acids Res 25:265, 1997
54. El-Deiry WS, Kern SE, Pietenpol JA, Kinzler KW, Vogelstein B: Definition of a consensus binding site for p53. Nat Genet 1:45, 1992
55. Funk WD, Pak DT, Karas RH, Wright WE, Shay JW: A transcriptionally active DNA-binding stite for human p53 protein complexes. Mol Cell Biol 12:2866, 1992
56. Bourdon J-C, Deguin-Chambon V, Lelong J-C, Dessen P, May P, Debuire B, May E: Further characterisation of the p53 responsive element-identification of new candidate genes for trans-activation by p53. Oncogene 14:85, 1997
57. Chin PL, Momand J, Pfeifer GP: In vivo evidence for binding of p53 to consensus binding sites in the p21 and GADD45 genes in response to ionizing radiation. Oncogene 15:87, 1997
58. Pavletich NP, Chambers KA, Pabo CO: The DNA-binding domain of p53 contains the four conserved regions and the major mutation hot spots. Genes Dev 7:2556, 1993
59. Lund-Johansen F, Terstappen LWMM: Differential surface expression of cell adhesion molecules during granulocyte maturation. J Leukoc Biol 54:47, 1993
60. Liu Y, Martindale JL, Gorospe M, Holbrook NJ: Regulation of p21(waf1/cip1) expression through mitogen-activated protein kinase signaling pathway. Cancer Res 56:31, 1996
61. Missero C, Cunto FD, Kiyokawa H, Koff A, Dotto GP: The absence of p21Cip1/WAF1 alters keratinocyte growth and differentiation and promotes ras-tumor progression. Genes Dev 10:3065, 1996
62. Zhang H, Hannon GJ, Beach D: p21-containing cyclin kinases exist in both active and inactive states. Genes Dev 8:1750, 1994
63. Labaer J, Garrett MD, Stevenson LF, Slingerland JM, Sandhu C, Chou HS, Fattaey A, Harlow E: New functional activities for the p21 family of CDK inhibitors. Genes Dev 11:847, 1997
64. Michieli P, Marcio C, Lin D, Pierce J H, Mercer WE, Givol D: Induction of WAF1/CIP1 by a p53-independent pathway. Cancer Res 54:3391, 1994
65. Kramer A, Carstens C-P, Fahl WE: A novel CCAAT-binding protein necessary for adhesion-dependent cyclin A transcription at the G1/S boundary is sequestered by a retinoblastoma-like protein in G0. J Biol Chem 271:6579, 1996
66. Rich CB, Goud HD, Bashir M, Rosenbloom J, Foster AA: Developmental regulation of aortic elastin gene expression involves disruption of an IGF-1 sensitive represser complex. Biochem Biophys Res Commun 196:1316, 1993
67. Swick AG, Lane MD: Identification of a transcriptional represser down-regulated during preadipocyte differentiation. Proc Natl Acad Sci USA 89:7895, 1992
68. Macleod K, Plumb M: Derepression of mouse beta-major-globin gene transcription during erythroid differentiation. Mol Cell Biol 11:4324, 1991